<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4069535</article-id><article-id pub-id-type="publisher-id">cc13607</article-id><article-id pub-id-type="doi">10.1186/cc13607</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Different effects of propofol and dexmedetomidine on preload dependency in endotoxemic shock with norepinephrine infusion: a randomized case-control study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Yu</surname><given-names>T</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Pan</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Liu</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Guo</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Longhini</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Yang</surname><given-names>Y</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Qiu</surname><given-names>H</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Zhong-Da Hospital, Southeast University, Nanjing, China</aff><aff id="I2"><label>2</label>Eastern Piedmont University ‘A. Avogadro, Novara, Italy</aff><pub-date pub-type="ppub"><year>2014</year></pub-date><pub-date pub-type="epub"><day>17</day><month>3</month><year>2014</year></pub-date><volume>18</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">34th International Symposium on Intensive Care and Emergency Medicine</named-content><named-content content-type="supplement-sponsor">Publication of this supplement was supported by ISICEM.</named-content></supplement><fpage>P417</fpage><lpage>P417</lpage><permissions><copyright-statement>Copyright © 2014 Yu et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Yu et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://ccforum.com/content/18/S1/P417"></self-uri><conference><conf-date>18-21 March 2014</conf-date><conf-name>34th International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title><offsets xml_i="4167" xml_f="4179" txt_i="7" txt_f="19">Introduction</offsets></title><p><offsets xml_i="4190" xml_f="4607" txt_i="20" txt_f="437">Septic shock is a status characterized by the simultaneous use of vasopressors and sedative drugs in critical care patients. Little is known about the possible interference of these drugs during shock status. We aimed to clarify how propofol could differently affect the preload dependency in an endotoxemic model in comparison with dexmedetomidine, by evaluation of the systemic vascular system and cardiac function.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="4648" xml_f="4655" txt_i="439" txt_f="446">Methods</offsets></title><p><offsets xml_i="4666" xml_f="4952" txt_i="447" txt_f="733">After animal preparation and under PiCCO monitoring (BL), endotoxemic shock was induced by an intravenous bolus of lipopolysaccharide (LPS, 055:B5) in ketamine-anesthetized rabbits. After fluid resuscitation and norepinephrine infusion (SD0), animals were randomized to propofol (PROP, </offsets><italic><offsets xml_i="4960" xml_f="4962" txt_i="733" txt_f="735">n </offsets></italic><offsets xml_i="4971" xml_f="5001" txt_i="735" txt_f="765">= 8) or dexmedetomidine (DEX, </offsets><italic><offsets xml_i="5009" xml_f="5011" txt_i="765" txt_f="767">n </offsets></italic><offsets xml_i="5020" xml_f="5588" txt_i="767" txt_f="1335">= 8) sedation, with two incremental doses (SD1 and SD2). The mean arterial pressure (MAP) and central vein pressure (CVP) were monitored. Pulse pressure variation (PPV) and stroke volume variation (SVV) were assessed to evaluate the preload dependency. Global end-diastolic volume, vascular resistances, mean systemic filling pressure, cardiac functional index and vascular resistances were assessed at each time point. Normality was assessed by the Kolmogorov-Smirnov test. Twoway analysis of variance for repeated measures was applied, and the Student-Newmann-Keuls </offsets><italic><offsets xml_i="5596" xml_f="5605" txt_i="1335" txt_f="1344">post-hoc </offsets></italic><offsets xml_i="5614" xml_f="5635" txt_i="1344" txt_f="1365">test when indicated. </offsets><italic><offsets xml_i="5643" xml_f="5645" txt_i="1365" txt_f="1367">P </offsets></italic><offsets xml_i="5654" xml_f="5691" txt_i="1367" txt_f="1401">&lt; 0.05 was considered significant.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="5732" xml_f="5739" txt_i="1403" txt_f="1410">Results</offsets></title><p><offsets xml_i="5750" xml_f="5846" txt_i="1411" txt_f="1507">At the increasing dose of propofol, both PPV and SVV significantly increased in SD1 versus SD0 (</offsets><italic><offsets xml_i="5854" xml_f="5856" txt_i="1507" txt_f="1509">P </offsets></italic><offsets xml_i="5865" xml_f="5896" txt_i="1509" txt_f="1537">&lt; 0.01) and SD2 versus SD0 (</offsets><italic><offsets xml_i="5904" xml_f="5906" txt_i="1537" txt_f="1539">P </offsets></italic><offsets xml_i="5915" xml_f="5960" txt_i="1539" txt_f="1581">&lt; 0.001), but only PPV in SD2 versus SD1 (</offsets><italic><offsets xml_i="5968" xml_f="5970" txt_i="1581" txt_f="1583">P </offsets></italic><offsets xml_i="5979" xml_f="6111" txt_i="1583" txt_f="1715">= 0.024). Dexmedetomidine infusion did not affect PPV and SVV. At SD1 and SD2, PPV and SVV were higher in PROP with respect to DEX (</offsets><italic><offsets xml_i="6119" xml_f="6121" txt_i="1715" txt_f="1717">P </offsets></italic><offsets xml_i="6130" xml_f="6529" txt_i="1717" txt_f="2113">&lt; 0.001). Moreover, propofol infusion increased the heart rate and had no effects on cardiac contractility and vascular resistances. On the contrary, in the DEX group we recorded a significant decrease in heart contractility and increment of vascular resistances at SD2. Nonetheless, both drugs affected the MAP, CVP, mean systemic filling pressure, global end-diastolic volume and venous return.</offsets></p></sec><sec sec-type="conclusions"><title><offsets xml_i="6574" xml_f="6584" txt_i="2115" txt_f="2125">Conclusion</offsets></title><p><offsets xml_i="6595" xml_f="6880" txt_i="2126" txt_f="2411">In an endotoxemic shock model, after fluid resuscitation and during norepinephrine infusion, propofol increased more PPV and SVV in comparison with dexmedetomidine. At high dosage the vascular resistances and heart contractility were influenced by dexmedetomidine, but not by propofol.</offsets></p></sec></body></article>